Eyevance Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Eyevance Pharmaceuticals's estimated annual revenue is currently $4.9M per year.
- Eyevance Pharmaceuticals's estimated revenue per employee is $100,500
- Eyevance Pharmaceuticals's total funding is $30M.
Employee Data
- Eyevance Pharmaceuticals has 49 Employees.
- Eyevance Pharmaceuticals grew their employee count by -40% last year.
Eyevance Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Market Access and Trade Channels | Reveal Email/Phone |
2 | Senior Ophthalmic Territory Manager | Reveal Email/Phone |
3 | Ocular Territory Manager | Reveal Email/Phone |
4 | Senior Ophthalmic Territory Manager | Reveal Email/Phone |
5 | Senior Ophthalmic Territory Manager | Reveal Email/Phone |
6 | Certified Field Trainer | Reveal Email/Phone |
7 | AP/AR Lead | Reveal Email/Phone |
Eyevance Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26.7M | 133 | 20% | N/A | N/A |
#2 | $13.5M | 67 | 6% | N/A | N/A |
#3 | $16.1M | 80 | -2% | N/A | N/A |
#4 | $62.5M | 0 | N/A | N/A | N/A |
#5 | $10.1M | 50 | 6% | N/A | N/A |
#6 | $119.4M | 594 | 27% | N/A | N/A |
#7 | $22.9M | 114 | 8% | N/A | N/A |
#8 | $92.9M | 462 | 8% | N/A | N/A |
#9 | $11.3M | 56 | -8% | N/A | N/A |
#10 | $7M | 35 | 6% | N/A | N/A |
What Is Eyevance Pharmaceuticals?
EYEVANCE Pharmaceuticalsￃﾢ￢ﾂﾬ￢ﾄﾢ mission is to develop and commercialize INNOVATIVE and IMPACTFUL ophthalmic products to enable optimal vision and better quality of life for all patients
keywords:N/A
$30M
Total Funding
49
Number of Employees
$4.9M
Revenue (est)
-40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Eyevance Pharmaceuticals News
2022-04-20 - Combination eye drop manages inflammation and infection ...
... anti-inflammatory and lubricant (Tobradex ST ophthalmic suspension, Eyevance Pharmaceuticals) managed inflammation and infection,...
2022-04-06 - Perioperative dry eye treatment necessary for best postop ...
... Sun Pharmaceutical) or Xiidra (lifitegrast ophthalmic solution 5%, Novartis). ... acetate as found in Flarex (Eyevance Pharmaceuticals).
2022-04-06 - Nicox's NCX 470 Dolomites Phase 2 Results Published in ...
... in multiple geographies, including to Eyevance Pharmaceuticals, LLC, ... of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.
Other Companies in Fort Worth
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.2M | 49 | 4% | N/A |
#2 | $15M | 49 | 4% | N/A |
#3 | $8.9M | 49 | 0% | N/A |
#4 | $11.6M | 50 | 6% | N/A |
#5 | $9.8M | 50 | 6% | N/A |